Agilent Technologies Cash on Hand 2010-2025 | A

Agilent Technologies cash on hand from 2010 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Agilent Technologies cash on hand for the quarter ending April 30, 2025 was $1.467B, a 16.08% decline year-over-year.
  • Agilent Technologies cash on hand for 2024 was $1.329B, a 16.42% decline from 2023.
  • Agilent Technologies cash on hand for 2023 was $1.59B, a 51% increase from 2022.
  • Agilent Technologies cash on hand for 2022 was $1.053B, a 33.14% decline from 2021.
Agilent Technologies Annual Cash on Hand
(Millions of US $)
2024 $1,329
2023 $1,590
2022 $1,053
2021 $1,575
2020 $1,441
2019 $1,382
2018 $2,247
2017 $2,678
2016 $2,289
2015 $2,245
2014 $2,218
2013 $2,675
2012 $2,351
2011 $3,527
2010 $4,199
2009 $2,493
Agilent Technologies Quarterly Cash on Hand
(Millions of US $)
2025-01-31 $1,467
2024-10-31 $1,329
2024-07-31 $1,779
2024-04-30 $1,671
2024-01-31 $1,748
2023-10-31 $1,590
2023-07-31 $1,329
2023-04-30 $1,175
2023-01-31 $1,250
2022-10-31 $1,053
2022-07-31 $1,077
2022-04-30 $1,207
2022-01-31 $1,158
2021-10-31 $1,575
2021-07-31 $1,428
2021-04-30 $1,380
2021-01-31 $1,329
2020-10-31 $1,441
2020-07-31 $1,358
2020-04-30 $1,324
2020-01-31 $1,226
2019-10-31 $1,382
2019-07-31 $1,765
2019-04-30 $2,155
2019-01-31 $2,057
2018-10-31 $2,247
2018-07-31 $2,131
2018-04-30 $3,011
2018-01-31 $2,887
2017-10-31 $2,678
2017-07-31 $2,563
2017-04-30 $2,389
2017-01-31 $2,241
2016-10-31 $2,289
2016-07-31 $2,199
2016-04-30 $2,139
2016-01-31 $1,931
2015-10-31 $2,245
2015-07-31 $2,075
2015-04-30 $2,197
2015-01-31 $2,118
2014-10-31 $2,218
2014-07-31 $2,391
2014-04-30 $2,950
2014-01-31 $2,742
2013-10-31 $2,675
2013-07-31 $2,330
2013-04-30 $2,519
2013-01-31 $2,450
2012-10-31 $2,351
2012-07-31 $1,923
2012-04-30 $3,896
2012-01-31 $3,662
2011-10-31 $3,527
2011-07-31 $3,101
2011-04-30 $2,975
2011-01-31 $2,655
2010-10-31 $4,199
2010-07-31 $3,868
2010-04-30 $4,209
2010-01-31 $4,046
2009-10-31 $2,493
2009-07-31 $1,499
2009-04-30 $1,412
2009-01-31 $1,380
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $34.235B $6.510B
Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $233.364B 28.06
Stryker (SYK) United States $146.969B 30.73
Boston Scientific (BSX) United States $146.968B 36.79
EssilorLuxottica (ESLOY) France $131.277B 0.00
Medtronic (MDT) Ireland $112.813B 15.99
Lonza Group Ag (LZAGY) Switzerland $50.710B 0.00
Haleon (HLN) United Kingdom $49.016B 27.92
ResMed (RMD) United States $37.047B 27.83
GE HealthCare Technologies (GEHC) United States $33.847B 16.07
Terumo (TRUMY) Japan $26.946B 35.00
Koninklijke Philips (PHG) Netherlands $22.399B 16.10
Insulet (PODD) United States $21.023B 82.52
Zimmer Biomet Holdings (ZBH) United States $18.780B 12.06
Baxter (BAX) United States $16.278B 12.15
Smith & Nephew SNATS (SNN) United Kingdom $13.165B 0.00
Sunny Optical Technology (SNPTF) China $9.076B 0.00
Demant (WILYY) Denmark $8.854B 0.00
Bio-Rad Laboratories (BIO) United States $6.273B 21.83
Lantheus Holdings (LNTH) United States $5.564B 14.03
Prestige Consumer Healthcare (PBH) United States $4.281B 19.13
Perrigo (PRGO) Ireland $3.794B 9.62
Haemonetics (HAE) United States $3.466B 15.79
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.367B 24.83
Envista Holdings (NVST) United States $3.244B 26.96
GN Store Nord (GNNDY) Denmark $2.180B 18.06
QuidelOrtho (QDEL) United States $2.091B 14.38
LeMaitre Vascular (LMAT) United States $1.890B 42.24
AtriCure (ATRC) United States $1.653B 0.00
Acuren (TIC) United States $1.314B 0.00
Neogen (NEOG) United States $1.268B 16.22
AdaptHealth (AHCO) United States $1.190B 12.08
BioLife Solutions (BLFS) United States $1.136B 0.00
Green Thumb Industries (GTBIF) United States $1.063B 23.91
Kestra Medical Technologies (KMTS) United States $1.053B 0.00
Phibro Animal Health (PAHC) United States $0.987B 12.61
InMode (INMD) Israel $0.920B 9.27
CeriBell (CBLL) United States $0.640B 0.00
Evolus (EOLS) United States $0.636B 0.00
Capricor Therapeutics (CAPR) United States $0.634B 0.00
Owens & Minor (OMI) United States $0.629B 5.22
Curaleaf Holdings (CURLF) Canada $0.565B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.550B 0.00
Valneva SE (VALN) France $0.535B 0.00
Tilray Brands (TLRY) Canada $0.422B 0.00
Surmodics (SRDX) United States $0.418B 0.00
VAREX IMAGING (VREX) United States $0.367B 13.50
SNDL (SNDL) Canada $0.347B 0.00
Aurora Cannabis (ACB) Canada $0.334B 59.50
SEMPERIT AG HLD (SEIGY) Austria $0.283B 0.00
Canopy Growth (CGC) Canada $0.276B 0.00
Cerus (CERS) United States $0.275B 0.00
Viemed Healthcare (VMD) United States $0.273B 23.00
ZimVie (ZIMV) United States $0.266B 12.09
Sanara MedTech (SMTI) United States $0.265B 0.00
Sanuwave Health (SNWV) United States $0.264B 0.00
Quanterix (QTRX) United States $0.256B 0.00
Cresco Labs (CRLBF) United States $0.253B 0.00
Omeros (OMER) United States $0.227B 0.00
Biote (BTMD) United States $0.227B 6.37
OraSure Technologies (OSUR) United States $0.224B 0.00
Brainsway (BWAY) Israel $0.216B 57.30
TriSalus Life Sciences (TLSI) United States $0.211B 0.00
Organigram Global (OGI) Canada $0.191B 0.00
High Tide (HITI) Canada $0.188B 0.00
Utah Medical Products (UTMD) United States $0.186B 15.16
Verano Holdings (VRNOF) United States $0.180B 0.00
Exagen (XGN) United States $0.157B 0.00
Vireo Growth (VREOF) United States $0.133B 0.00
FitLife Brands (FTLF) United States $0.131B 16.18
MacroGenics (MGNX) United States $0.112B 0.00
Jin Medical (ZJYL) China $0.105B 0.00
Veru (VERU) United States $0.098B 0.00
Fonar (FONR) United States $0.092B 11.88
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Quipt Home Medical (QIPT) United States $0.090B 0.00
Agape ATP (ATPC) $0.079B 0.00
TerrAscend (TSNDF) Canada $0.074B 0.00
Apyx Medical (APYX) United States $0.069B 0.00
InterCure (INCR) Israel $0.067B 0.00
Cytosorbents (CTSO) United States $0.066B 0.00
Zynex (ZYXI) United States $0.066B 0.00
Jushi Holdings (JUSHF) United States $0.059B 0.00
ImmuCell (ICCC) United States $0.057B 0.00
Modular Medical (MODD) United States $0.045B 0.00
Nephros (NEPH) United States $0.041B 55.43
United-Guardian (UG) United States $0.037B 12.94
Rockwell Medical (RMTI) United States $0.035B 0.00
Safety Shot (SHOT) United States $0.020B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
Cellectar Biosciences (CLRB) United States $0.017B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
INLIF (INLF) $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00